ONCOLife Articles
How AI Innovations Are Transforming Breast Cancer Screening
30 January 2025
How AI Could Overcome Data Scarcity to Transform Medicine
10 January 2025
Ribociclib Shows Promising Long-Term Benefits in Early Breast Cancer Treatment
Clinical Trials | 12 December 2024
How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing
ONCOLife | 16 December 2024
Palbociclib Combination Yields PFS Improvement in HR+, HER2+ Breast Cancer
Clinical Trials | 14 December 2024
Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2- Breast Cancer
Clinical Trials | 13 December 2024
IL-15 Agonist NKTR-255 Enhances CAR-T Therapy Effectiveness in LB-Cell Lymphoma
Clinical Trials | 11 December 2024
Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer
Clinical Trials | 12 December 2024
Blenrep Combination Reduces Death Risk by 42% in Relapsed Multiple Myeloma
Clinical Trials | 10 December 2024
Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA
Clinical Trials | 10 December 2024
AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors
AI
6 December 2024
AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer
AI
29 November 2024
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA
27 November 2024
SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer
Clinical Trials
26 November 2024
FDA Greenlights Revumenib for Relapsed Leukemia Treatment
ONCOLife
23 November 2024
FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer
ONCOLife
22 November 2024
How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment
ONCOLife
20 November 2024
UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets
ONCOLife
19 November 2024
FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy
ONCOLife
9 November 2024
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
